Loading...

Accolade Inc
NASDAQ:ACCD

Watchlist Manager
Accolade Inc Logo
Accolade Inc
NASDAQ:ACCD
Watchlist
Price: 8.83 USD +7.68% Market Closed
Updated: Dec 1, 2022

Intrinsic Value

The intrinsic value of one ACCD stock under the Base Case scenario is 10.95 USD. Compared to the current market price of 8.83 USD, Accolade Inc is Undervalued by 19%.

The Intrinsic Value is calculated as the average of the two valuation methods:

ACCD Intrinsic Value
Base Case
10.95 USD
Undervaluation 19%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

ACCD Profitability Score
Profitability Due Diligence

Accolade Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Negative 3-Year Average ROIC
Negative Free Cash Flow
Negative Operating Income
Negative Net Income
38/100
Profitability
Score

Accolade Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

ACCD Solvency Score
Solvency Due Diligence

Accolade Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Low Interest Coverage
Low Altman Z-Score
Negative Net Debt
Long-Term Liabilities
43/100
Solvency
Score

Accolade Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
46%
Gross Margin
-35%
Operating Margin
-124%
Net Margin
-21%
FCF Margin
-86%
ROE
-22%
ROIC
Other

ACCD Capital Structure
Accolade Inc

Market Capitalization 615M USD
Total Debt 281M USD
Minority Interest 0 USD
Preferred Equity 0 USD
Cash and Equivalents 336M USD
Short-Term Investments 0 USD
Enterprise Value 560M USD

Wall St
Price Targets

ACCD Price Targets Summary
Accolade Inc

Wall Street analysts forecast ACCD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACCD is 14.21 USD with a low forecast of 10.1 USD and a high forecast of 17.85 USD.

Lowest
Price Target
10.1 USD
14% Upside
Average
Price Target
14.21 USD
61% Upside
Highest
Price Target
17.85 USD
102% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

ACCD Competitors
Accolade Inc

ACCD Suppliers & Customers
Accolade Inc

Accolade Inc has 4 key suppliers from 1 countries and 3 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Health Care industry.

Accolade Inc has 4 key customers from 1 countries and 4 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Health Care industry.

Ownership

ACCD Shareholders
Major Shareholders

Insiders own a significant part of the company.

Top 25 shareholders own 78.28% of the company. Insiders own 18.88%. The biggest insider is Ah Parallel Fund Iv, L.p. (10 percent owner), who owns 5.2% of Accolade Inc.

Insiders
18.88%
Institutions
72.2%
Other
8.92%
Insiders
18.88%
Ah Parallel Fund Iv, L.p.
10 percent owner
Ownership
5.2046%
Market Value
33.1M USD
Shares
3 744 165
Carrick Capital Partners Ii Co-Investment Fund Ii, L.p.
Other
Ownership
4.8767%
Market Value
31M USD
Shares
3 508 278
Singh Rajeev
Chief Executive Officer
Ownership
2.4101%
Market Value
15.3M USD
Shares
1 733 804
Andreessen Horowitz Fund Iv, L.p.
10 percent owner
Ownership
2.2506%
Market Value
14.3M USD
Shares
1 619 088
Cline J Michael
Former 10% Owner
Ownership
1.92%
Market Value
12.2M USD
Shares
1 381 255
Bronfman Edgar Jr
Former 10% Owner
Ownership
0.5086%
Market Value
3.2M USD
Shares
365 878
Frist William H.
Director
Ownership
0.4286%
Market Value
2.7M USD
Shares
308 313
Barnes Stephen H.
Chief Financial Officer
Ownership
0.3357%
Market Value
2.1M USD
Shares
241 518
Cavanaugh Robert N
President
Ownership
0.2945%
Market Value
1.9M USD
Shares
211 843
Madden James C.
Fomer Director
Ownership
0.247%
Market Value
1.6M USD
Shares
177 657
Hilton Michael W
Chief Innovation Officer
Ownership
0.2126%
Market Value
1.4M USD
Shares
152 935
Neff Thomas J
Director
Ownership
0.058%
Market Value
369k USD
Shares
41 755
Wadors Patricia L
Director
Ownership
0.0258%
Market Value
164k USD
Shares
18 563
Jordan Jeffrey D
Director
Ownership
0.0258%
Market Value
164k USD
Shares
18 563
Nabel Elizabeth G
Director
Ownership
0.0237%
Market Value
151k USD
Shares
17 065
Kent Cindy
Director
Ownership
0.0214%
Market Value
136k USD
Shares
15 420
Lepore Dawn G
Director
Ownership
0.0195%
Market Value
124k USD
Shares
14 060
Brodsky Jeffrey S
Director
Ownership
0.0109%
Market Value
69.2k USD
Shares
7 833
Klein Peter S
Director
Ownership
0.0071%
Market Value
44.8k USD
Shares
5 073
Institutions
72.2%
Back

ACCD Insider Trading
Buy and sell transactions by insiders

Accolade Inc insiders have bought more shares than they have sold in the past 12 months.

During the last 12 months Accolade Inc insiders bought 177k USD , and sold 68.9k USD worth of shares. The last transaction was made on Dec 1, 2022 by Singh Rajeev (Chief Executive Officer), who sold 2.1k USD worth of ACCD shares.

Sold
0-3
months
18.6k USD
4
3-6
months
50.3k USD
4
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
0
0 USD
3-6
months
1
177k USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
18.6k USD
N/A
-18.6k
6 Months
68.9k USD
177k USD
108k
9 Months
68.9k USD
177k USD
108k
12 Months
68.9k USD
177k USD
108k
Purchases
1
Sales
31
Why is insider trading important?

Shareholder Return

ACCD Price
Accolade Inc

1M 1M
-19%
6M 6M
+51%
1Y 1Y
-64%
3Y 3Y
-70%
5Y 5Y
-70%
Annual Price Range
8.83
52w Low
5.28
52w High
27.18
Price Metrics
Average Annual Return 39.56%
Standard Deviation of Annual Returns
N/A
Max Drawdown -91%

Company Profile

Accolade Inc

Country

United States of America

Industry

Health Care

Market Cap

615M USD

Dividend Yield

0%

Description

Accolade, Inc. engages in the provision of personalized health and benefits solutions. The company is headquartered in Seattle, Washington and currently employs 2,350 full-time employees. The company went IPO on 2020-07-02. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. The firm leverages its integrated capabilities, connectivity with providers and the healthcare ecosystem, and longitudinal data to engage across the member population. Its offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits, Accolade Boost, the Trusted Supplier Program, and Mental Health Integrated Care solutions.

Contact

WASHINGTON
Seattle
1201 Third Avenue, Suite 1700
+12069268100.0
https://www.accolade.com

IPO

2020-07-02

Employees

2 350

Officers

Chairman & CEO
Mr. Rajeev Singh
Pres
Mr. Robert Cavanaugh
CFO & Treasurer
Mr. Stephen H. Barnes CPA
Chief Innovation Officer
Mr. Michael W. Hilton
Chief Operating Officer
Mr. Phong Nguyen
Sr. VP of Investor Relations
Mr. Todd Friedman
Show More
EVP, Gen. Counsel, CCO & Sec.
Mr. Richard Eskew
Chief Marketing Officer
Ms. Carolina Lobo
VP of Strategy, Corp. Devel. & Partnerships
Ms. Kristen Keating Weeks
Exec. VP of People and Culture & Chief HR Officer
Ms. Jennifer Hanson
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one ACCD stock?

The intrinsic value of one ACCD stock under the Base Case scenario is 10.95 USD.

Is ACCD stock undervalued or overvalued?

Compared to the current market price of 8.83 USD, Accolade Inc is Undervalued by 19%.